Archives: News

In order to improve market access of medical technology, Kalam Institute of Health Technology (KIHT) has got formally inducted as a Joanna Briggs Institute (JBI) for India for evidence synthesis and technology assessments. This development took place on October 15, 2018 which happens to be the birthday of Dr. A P J Abdul Kalam.

The structured approach of the JBI system is to generate evidence by carrying out bonafide systematic review and meta-analysis through engaging international groups of JBI. The process of developing transparent and evidence-based decision-making for health technologies would add value to the innovative product credibility.

The research arm of AMTZ, KIHT has collaborated with JBI as an affiliate as it is a premium research and development centre, under health and medical sciences at the University of Adelaide, South Australia. The Institute supports development of evidences to improve healthcare outcomes globally and implement such outcomes by seeking feasibility, appropriateness, meaning and effectiveness. JBI collaborates with around 70 entities across globe.

The affiliation group formed in collaboration with KIHT for JBI standards to the health technology landscape strengthens the health technology assessment (HTA) programme under KIHT. It also opens up avenues for government, academia as well as private partners in more validated health access avenues in the country, adding another feather to the growing recognition of the MedTech capital of the country acclaimed worldwide.

A Letter of Intent (LoI) has earlier been signed between BioCubaFarma, Biotechnology Industry Research Assistance Council (BIRAC) and KIHT with focus on exchange of technologies, products,  innovations, transfer of technologies and commercialization of innovative healthcare products of interest to both the countries.

BioCubaFarma is the Cuban organization of biotechnology and pharmaceutical industries which manages the country’s efforts towards manufacturing medicines, diagnostics and medical equipment. It also serves as a gateway for potential partners and investors interested in accessing the extensive biopharma resources Cuba has to offer.

KIHT is the premier institute of the country for promoting back end support to the growing medical technology and plays an active role in supporting activities related to research on critical components of health technologies, commercial exploitation of newer technologies, apart from being a front runner in providing regulatory and non-regulatory support for stakeholders in health technologies.

KIHT which was conceived a year ago ushers in focused research on critical components pertaining to medical devices with support from various stakeholder institutions. Conceived as a research facilitation institution by former Principal Scientific Advisor (PSA) to the Government of India, the premier Institution of the country for medical devices completed its first year on 17th July, 2018.

It is also collaborating with Tata Institute of Social Science (TISS), Mumbai for taking fellowship programme to the next level by converting it to executive programme on health technology policy, assessment and outcomes research.

In its one year, KIHT has made giant leaps and was notified by the office of the PSA in June 2018 as the project analysis unit for all health technology projects in the country. This was preceded by a meeting convened by the PSA on April 30, 2018 at the KIHT campus with a host of country’s leading R&D institutions working on medical technology for taking stock of the status of projects which received government funding in the health technology domain.

KIHT, inter-alia, has achieved the following in its one year – first ever E-Auction for medical technologies launched on 15th February 2018 by ministry of chemicals and fertilizers, around 22 technologies identified for technology transfer of intellectual property and prototypes, bringing strategic and coherent synergy of scientific facilities and research institutions with industrial promotion, signed MoU with 12 institutions for technology collaboration and bringing vibrancy into the medical devices fraternity, carried out first of its kind disease burden and trade deficit amalgamated model to create the national priority list which formed the backbone for the National BioPharma Mission. This was the first of its kind need and trade-based grant release for R&D in any sector of science.

KIHT also created a knowledge repository for trade information, analyzing emerging trends in trade and investments, towards policy enabling inputs to the government. It also launched a pioneer initiative named Non-regulatory Innovation Potential Utility and Novelty (NIPUN) certificate to act as a single point window for all non-regulatory requirements of the medical technology sector and provide a simplified approach to the process of the commercialization of a product.

It also promulgated health technology as one of the core component of market access which adds value to the product credibility by giving them comparative overview of clinical and economic effectiveness of the innovation with its systematic, transparent and evidence-based decision-making process. KIHT joined the presidential delegation from India to Cuba in June 2018 as a key stakeholder in promoting bilateral bio-technology collaboration.

A tripartite MoU between KIHT, BIRAC and ‘BioCubaFarma’ was signed in the past to facilitate several stakeholders, including industry, R&D Institutes and technology transfer offices and pave the way for technological and industrial progress in health technology sector.

As part of its constant endeavour to cater to the needs of the medical devices industry, KIHT came out with unique type of dossiers to disseminate information specific to devices in healthcare which are complex in technology and import dependent. These dossiers capture key features of a product like design, technology, market share, etc. and facilitates users like start-ups, researchers, academicians, manufacturers and other stakeholders in taking decisions on R&D, investment, potential market, innovations etc.

It has been conducting periodic training sessions on medical devices and their functionality with hands on session by experts on the actual device itself.

Source

Congratulating Kalam Institute of Health Technology (KIHT), the premier Institution of the country for medical devices on completion of its first successful year on 17th July 2018 and appreciating the excellent progress made by KIHT in just a small span of time, Rajiv Nath, Forum Coordinator, AiMED said, “We are very happy to celebrate the first anniversary of KIHT which showed commendable progress in such a short span of time. Association of Indian Medical Device Industry (AiMeD) is delighted to be on KIHT’s Governing Board of Directors.” Rajiv Nath felicitated Dr Jitendra Sharma, Executive Director, KIHT and the whole team of KIHT for their excellent accomplishments. “KIHT is a major step towards making India a Global Manufacturing Hub for medical device sector and to build a robust system for innovation in the medical devices sector in the country,” said Nath.

Conceived as a research facilitation institution by the former Principal Scientific Advisor (PSA) to the Government of India, KIHT was born one year ago with a mandate from the Department of Bio-Technology to act the nodal institution of the country for facilitating focused research on critical components pertaining to medical devices with support from various stakeholder institutions. In its first year, KIHT launched first ever e-Auction for medical technologies, 22 technologies identified for technology transfer of intellectual property and prototypes, bringing strategic and coherent synergy of scientific facilities and research institutions with industrial promotion and signed MoU with 12 institutions for technology collaboration and bringing vibrancy into the medical devices fraternity. The KIHT also launched a pioneer initiative named NIPUN Certificate which is a non-regulatory Innovation Potential Utility and novelty certificate to help developers and start-ups to act as a single point window for all non-regulatory requirements of the medical technology sector and provide a simplified approach to the process of the commercialisation of a product.

The KIHT was also declared as the regional hub for conducting Health Technology Assessment (HTA) for Department of Health Research, Ministry of Health and Family Welfare. Conducting periodic training sessions and workshops on medical devices and their functionality with hands on session by experts on the actual device itself. Such level of close proximity to actual operating medical devices and in-depth learning has been unprecedented. AiMED is also advocating for the development of more medical devices manufacturing supporting infrastructure in other zones and regions of India.  “Our first focus is to create the required ecosystem and enabling policies to support medical devices manufacturing in India.” Added Rajiv Nath. – Medical Buyer Bureau

Source

Publish Date : June 28, 2018